KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 76 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,195,438 | +7.6% | 68,822 | -12.7% | 0.00% | +100.0% |
Q2 2023 | $1,110,560 | -18.4% | 78,875 | -37.7% | 0.00% | -50.0% |
Q1 2023 | $1,361,635 | +159.7% | 126,546 | +261.6% | 0.00% | +100.0% |
Q4 2022 | $524,285 | -99.6% | 34,999 | +224.3% | 0.00% | – |
Q3 2022 | $138,569,000 | -15.6% | 10,792 | -36.3% | 0.00% | – |
Q2 2022 | $164,149,000 | -73.0% | 16,940 | -72.3% | 0.00% | -100.0% |
Q1 2022 | $608,298,000 | -9.2% | 61,197 | +7.5% | 0.00% | 0.0% |
Q4 2021 | $669,807,000 | +944.0% | 56,908 | +910.3% | 0.00% | – |
Q3 2021 | $64,160,000 | +328.8% | 5,633 | +424.5% | 0.00% | – |
Q2 2021 | $14,961,000 | -76.9% | 1,074 | -69.3% | 0.00% | – |
Q1 2021 | $64,766,000 | +18.8% | 3,499 | +13.4% | 0.00% | – |
Q4 2020 | $54,512,000 | -44.3% | 3,085 | -51.7% | 0.00% | – |
Q3 2020 | $97,895,000 | +177.0% | 6,390 | +360.7% | 0.00% | – |
Q2 2020 | $35,341,000 | -49.6% | 1,387 | -69.4% | 0.00% | – |
Q1 2020 | $70,062,000 | +182.5% | 4,526 | +101.9% | 0.00% | – |
Q4 2019 | $24,797,000 | +31.5% | 2,242 | +1.2% | 0.00% | – |
Q3 2019 | $18,858,000 | -9.4% | 2,216 | +44.2% | 0.00% | – |
Q2 2019 | $20,811,000 | -57.1% | 1,537 | -42.8% | 0.00% | – |
Q1 2019 | $48,491,000 | +691.8% | 2,685 | +1131.7% | 0.00% | – |
Q4 2018 | $6,124,000 | +74.0% | 218 | +58.0% | 0.00% | – |
Q3 2018 | $3,519,000 | – | 138 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 639,230 | $11,091,000 | 3.32% |
Boxer Capital, LLC | 1,172,700 | $20,346,000 | 2.30% |
Sofinnova Investments, Inc. | 1,845,400 | $32,018,000 | 2.04% |
Hillhouse Capital Management | 5,736,527 | $99,529,000 | 1.70% |
Cormorant Asset Management, LP | 831,000 | $13,842,000 | 1.02% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,226,890 | $21,287,000 | 0.75% |
Foresite Capital Management IV, LLC | 94,477 | $1,639,000 | 0.56% |
Vivo Capital, LLC | 186,073 | $3,228,000 | 0.42% |
Baker Brothers Advisors | 3,000,000 | $52,050,000 | 0.39% |
DC Investments Management, LLC | 30,817 | $535,000 | 0.34% |